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FATIGUE PILOT STUDY AMONG BONE MARROW TRANSPLANT
PATIENTS
Burke, A.; Neumann, J.; Cohen, M.; Jacob, R.; Johnston, P. University
of Texas M.D. Anderson Cancer Center, Houston, Texas
Fatigue was identiﬁed on our outcomes tracking tool as a major
alteration experienced by the BMT patients on our 52-bed unit.
Our unit-based advanced practice nurse with a nurse researcher
and support of the nurse manager convened an interdisciplinary
committee to develop a pilot study examining the incidence and
interventions helpful in decrease fatigue among the BMT patients.
A group of 10-12 nurses from our unit based research, clinical
practice, and education councils participated in the planning and
the implementation of the pilot study. The baseline data was col-
lected on 49 patients that consisted of demographics, MDASI
(MD Anderson Symptom Inventory), disease-related factors, and
quality of life (FACT-BMT and Brief Fatigue Inventory). This
was then repeated weekly for three weeks. Criterion for the pilot
study was established and information packets for the patients
were developed. The packets included the data collection tool,
interdisciplinary fatigue logs (kept at the bedside), consents, and
patient education materials. The patient education material con-
sisted of a nutrition guide, support group schedules, exercise
group schedules and a BMT Pathway to Recovery document. The
council nurses were divided into pairs and were responsible for
consenting 13 patients. Though weekly compliance varied, family
members, nursing staff and interdisciplinary team members assist-
ed the patient with the completion of the measures aimed at
reducing fatigue. According to feedback from patients, the
involvement in the interventions helped to relieve fatigue and dis-
tress. Results from this pilot study and informal feedback received
from the patients have been used to help identify further teaching
needs and to improve the activities that are used with our BMT
patients. The clinical nurses felt that although this added to their
workload it was a worthwhile endeavor.
USING SHARED GOVERNANCE COUNCILS TO DEVELOP AND IMPLE-
MENT A STANDARD OF CARE AND UNIT-BASED COMPETENCIES ON A
BMT UNIT
Causton, C.; Neumann, J.; dela Cruz, B.; Montinez, S.; Saquin, E.;
Lofranco, E.; Rios, R.; Largo, P.; Cabangan, C.; Jacob, R. University of
Texas M.D. Anderson Cancer Center, Houston, Texas
Our institutional nursing governing body utilizes a shared gov-
ernance model. We introduced this structure on our 52 bed BMT
unit to promote professional development and participation in the
decision making process. The councils are led by a staff nurse with
a facilitator, a clinical nurse specialist, manager, or educator.
Our unit-based councils actively participate in the development
and implementation of nursing care standards and unit based
competencies. In May 2000, we developed a standard of care for
the introduction of telemetry monitored beds. The Clinical Prac-
tice Council conducted research into the standards on other mon-
itored units, then adapted them to the needs of our patient popu-
lation. Through bimonthly meetings, the council discussed each
item at length. When the ﬁnal draft was completed, it was pre-
sented to the medical director for approval and then to the unit
based Education Council for implementation. Our nurse educator
and the council developed a system of telemetry classes and com-
petency checks for the staff. The communication council was then
responsible for creating a reference guide with these standards.
We proceeded to develop nursing care standards and unit base
competencies speciﬁc to transplant nursing, such as administration
of high dose chemotherapy and immunosuppressants. Council
members researched topics and then presented them to the group.
After discussion and approval from the medical director, they were
submitted to the education council for implementation and devel-
opment of annual testing. There was also an institutional mandate
for unit based competencies.
Though many BMT nursing skills are introduced during orien-
tation, inconsistent practice often develops. With a large staff and
varying amounts of BMT experience, it is critical to ensure a high
standard of patient care. We will be developing a tool in order to
measure the results of this.
UTILIZING A PATIENT-CENTERED CHECKLIST WITH BONE MARROW
TRANSPLANT PATIENTS TO IMPROVE THE DISCHARGE PROCESS
Jacob, R.. University of Texas M.D. Anderson Cancer Center, Houston,
Texas
The day of discharge can often be an overwhelming experience for
bone marrow transplant patients and their caregivers, as evidenced
by patient satisfaction surveys. After weeks of aggressive therapy and
monitoring, the shift to a less intensive environment outside of the
hospital is often met with feelings of trepidation and uncertainty. By
anticipating the goals and requirements for discharge, the patient is
better prepared for the adjustment. This discharge checklist was
created to serve as a basis for communication across multiple disci-
plines. It is a fourteen item checklist which includes activities to be
performed by nurses, pharmacists, social workers, case managers,
advanced practice nurses, and most importantly, the patient. Each
has clearly delineated roles to play in each patient’s discharge. Once
the patient has recovered a white blood cell count, has adequate oral
intake, and has no signs or symptoms of infection, the discharge
checklist is activated and posted at the patient’s room. Upon com-
pletion of their own respective tasks, the members of the team check
off, initial, and date it. The patient and caregivers can track the dif-
ferent components of the discharge process and also the impact of
their own roles. In this way, there are no surprises and the patient
and caregivers know exactly what to expect of each staff member.
They are also better prepared with questions for each of the disci-
plines. The checklist has been very well received from everyone
involved with it. Patient satisfaction survey scores have shown a sig-
niﬁcant improvement related to discharge. This tool can be adapted
and modiﬁed to meet the needs of various patient populations to
improve the quality of care that we deliver to our patients.
PATIENT PROFILE TOOL: A PATIENT CLASSIFICATION SYSTEM TO
DETERMINE PATIENT ACUITY TO PROVIDE SAFE, COST-EFFECTIVE
CARE LEVELS
Johnston, P.; Jewell, J.; Jacob, R. University of Texas M.D. Anderson
Cancer Center, Houston, Texas
Patient Classification Systems (PCSs) have been used in many
acute care institutions since the 1960s to provide nursing adminis-
trators with objective evidence to support stafﬁng and budgetary
needs. It allows patients to be grouped according to the type and
amount of nursing care required and meets the JCAHO standard,
which speciﬁes that individual unit stafﬁng needs be identiﬁed based
on patient acuity. The PCS also improves nursing resource utiliza-
tion which contributes to our organizational cost control efforts.
A Patient Proﬁle Tool was developed at our comprehensive can-
cer center to assist in staffing determinations and to calculate
stafﬁng productivity measurements on all oncology units includ-
ing BMT and ICU.
The system is composed of 7 categories/levels of care with corre-
sponding average nursing hours (direct and indirect) per patient day.
Each category is composed of 10 therapeutic indicators that are
descriptors of clinical situations requiring nursing interventions. Each
therapeutic indicator within a speciﬁed category requires the same
average number of nursing care hours per patient day. The nurse
classiﬁes the patient choosing the indicator that best matches the
patient’s condition. The hours of nursing care required per day for
the patient are calculated by the sum of each of the indicator scores.
Tool validity and inter-rater reliability is measured by compar-
ing two independent ratings using the established tool. The staff
nurse assigned to the patient completes the initial rating. A staff
member from another unit with the institution completes the sec-
ond rating. Units with similar oncology patient populations and
clinical experience are linked to complete the rating tool.
With Nurse Managers under continuing and escalating pressure
to balance quality patient care with cost effectiveness new
approaches must be developed, embraced and implemented.
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LINKING OF THE IBMTR AND INSTITUTIONAL DATABASES TO REPORT
OUTCOMES OF NK-CELLS, GVHD, RELAPSE AND DRUG THERAPY IN
PATIENTS RECEIVING ALLOGENEIC BONE MARROW TRANSPLANT
Jones, T.W.; Waller, E.K. Bone Marrow Transplant Program, Emory
University, Atlanta, Georgia
By utilizing IBMTR and Institutional laboratory and outcomes
databases, the BMT Program can directly export these data to sta-
tistical programs for analysis. These prospectively programmed
links reduce the time between entering data into databases and
analyses of the data. Utilizing historical Registry data from 1994
until 2000, that described incidence and severity of GVHD, post
transplant administration of growth factor, cause of death, and
pre-transplant drug and radiation therapy, we analyzed event free
survival and overall survival. This analysis was in conjunction with
demographic data and characteristics of the bone marrow allograft
contained within freestanding Institutional databases. Institutional
linked data included laboratory data (CD34+ cells, CD3+cells,
NK-cells and CD56+ T-cells in the graft) demographic tables
(age, sex, risk) and outcomes tables (overall survival, progression
free survival, relapse, last day of follow-up and last recorded
IBMTR interval of GVHD reporting). These data were linked
and exported into a single table and factored in univariate and
multivariate analysis. The analyses revealed that the content of
CD34+cells and CD4bright type 2 dendritic cells were signiﬁcant
factors with event free survival post allogeneic bone marrow
transplant.
QUALITY CONTROL ALGORITHMS FOR CLINICAL DATA RELATED TO
GVHD AND SUPPORTIVE CARE MEASURES IN PATIENTS RECEIVING
ALLOGENEIC BONE MARROW TRANSPLANTS
Jones, T.W.; Waller, E.K. Bone Marrow Transplant Program, Emory
University, Atlanta, Georgia
Our goal was to create mechanisms to prospectively analyze
clinical and laboratory data of transplant patients to detect errors
in the bone marrow transplant (BMT) database. Multiple ﬁelds in
the BMT database include dates and values related to transplant
events and clinical data that can be validated by writing algorithms
that check for inaccuracies. For example, algorithms that subtract
the BMT date from the start date of growth factor should gener-
ate a positive value indicating post transplant growth factor
administration. Negative numbers would indicate pre-transplant
administration of growth factor. Positive values can be further val-
idated to ensure the results are placed in the correct Registry
interval of 100 days, 1-year, 2-year etc. These algorithms are use-
ful when validating data including drug therapy, graft versus host
disease (GVHD), non-transplant medical or surgical events and
clinical outcomes. A database ﬁeld was created in order to catego-
rize patients as either high or low risk based upon their primary
disease, disease class and stage. This algorithm used a mathemati-
cal formula that added individual risk factors to generate a numer-
ical value that discriminates low risk from high risk patients. By
categorizing BMT patients as either high or low risk the program
can ensure that both groups are easily factored in univariate and
multivariate analyses. Analysis of these patient populations can be
run at any time without having to manually assign a risk factor to
patients at they are accrued. Utilizing multiple BMT database
tables and speciﬁc values previously assigned by the IBMTR, com-
puter algorithms can be written in order to organize data and to
have immediate access to statistical outcomes.
THE ADVANCE PRACTICE NURSE ROLE IN FACILITATING LONG-TERM
FOLLOW UP IN ALLOGENEIC BMT PATIENTS
Metoyor, L.; Neumann, J.; Champlin, R. University of Texas M.D.
Anderson Cancer Center, Houston, Texas
Allogeneic bone marrow transplant (BMT) patients may experi-
ence multiple complications and infections that develop after the
initial 100-day period. These complications may be beyond the
available level of support or the normal scope of practice of local
physicians. Therefore, out BMT service has developed a follow-up
program in which an advanced practice nurse is responsible to
closely monitor patients who are discharged to various states and
countries. This program has allowed for continuity of care and a
collaborative approach with the local physician and the treating
facility.
The follow-up includes close telephone assessment, triage, and
frequent lab reviews, including management of tacrolimus levels
and other appropriate interventions. Seemingly minor clinical
situations can be potentially life threatening for the allogeneic
patient. When intercepted appropriately, the interventions can
frequently be managed in the community setting. The accessibil-
ity to an advanced practice nurse, who is familiar with the
patient, has facilitated the patient’s return to our facility when
necessary. This has also proven to be asset for both the local
physicians, as well as the attending physician at our facility.
We are currently developing a clinical pathway to address
patients’ significant milestones and help identify other potential
problems, such as CMV and chronic GVHD. Continued patient
teaching and the education of local care providers has also proved
to be instrumental in preventive patient problems. As this pro-
gram continues to grow and develop, it will greatly enhance our
efforts to make out BMT program a seamless operation, initiated
in the pre-transplant stage and continued throughout the entire
transplant process.
A MULTIDISCIPLINARY APPROACH TO DEVELOPING AND IMPLE-
MENTING AN INPATIENT ALLOGENEIC/MATCHED UNRELATED DONOR
DISCHARGE TEACHING CLASS
Meyers, A.; Rivera, Z.; Neumann, J.; Hicks, K.; Kendall, D.; Martin,
C.; Zipes, K.; Cobb, D.; Jacob, R. University of Texas M.D. Anderson
Cancer Center, Houston, Texas
Transitioning from an intensive inpatient setting to a more inde-
pendent outpatient environment can often be stressful for bone
marrow transplant patients and their caregivers. A smooth transi-
tion can help to diminish feelings of insecurity when the level of
care and monitoring are decreased. In response to low patient sat-
isfaction results and outcomes tracking reports related to dis-
charge, our patient education quality improvement committee
developed a discharge teaching class for allogeneic and matched
unrelated donor patients. Effective and ongoing teaching can alle-
viate fears and anxieties (Buchsel & Kapustay). The allogeneic dis-
charge team has representation from nursing, pharmacy, rehabili-
tation, dietary, social work, case management, and chaplaincy, who
all prepare teaching material. The class meets once a week for two
hours and is designed to meet the educational needs of patients
and caregivers who will be discharged within the next seven days.
Patients are encouraged to ask questions and often are able to
share valuable experiences and perspectives with other partici-
pants. Prepared written information is given to all attendees of the
class. After attending the class, patients and caregivers report feel-
ing more prepared on day of discharge. The class has also expedit-
ed the discharge process and has provided consistency in the con-
tent that is taught. To further assess the class effectiveness, we will
be developing a patient survey and addressing individual learning
styles to incorporate different teaching strategies into the class.
DEVELOPMENT OF A MULTIDISCIPLINARY CHRONIC GRAFT VERUS
HOST CLINIC FOR PATIENTS AFTER ALLOGENEIC BLOOD AND MAR-
ROW TRANSPLANTATION
Neumann, J.; Ippoliti, C.; Hsu, Y.; Couriel, D. University of Texas
M.D. Anderson Cancer Center, Houston, Texas
The incidence of graft versus host disease (GVHD) in the post
allo blood and marrow transplantation (BMT) patient can
approach 50%, depending on the degree of disparity. While the
incidence of chronic graft versus host disease (cGVHD) is less, the
complications can be serious and greatly impair the patient’s qual-
ity of life. In our comprehensive cancer center, we performed over
600 transplantations last year and approximately 50% allogeneic.
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We have 13 BMT physicians, 10 advanced practice nurses (APN),
5 PharmD’s, and 5 physician assistants (PA). The patient care in
the pre-BMT and post-BMT (ﬁrst 100 days) phase has been stan-
dardized. After this period of time, follow-up was varied and data
collection and patient outcomes were inconsistently gathered. In
the midst of research, new treatment options for cGVHD patients
were frequently missed or not included in potentially beneficial
studies.
After the identiﬁcation of interested healthcare practitioners, the
group met and developed guidelines and methods to conduct the
clinic. Representation included medicine, nursing, pharmacy,
physical therapy, social work, and psychiatry. The clinic started
with referrals from the BMT physician group, but they were also
obtained from the research nurses and the APN assigned to the
long-term follow-up clinic. The patients were scheduled to clinic
visits two afternoons per week and were seen by the MD or APN.
A focused assessment was performed that included a quality of life
assessment. A pathway for the treatment of chronic (GVHD) has
been developed and the data about this patient population is being
collected.
NURSING MANAGEMENT OF THE BMT PATIENT WITH GI GRAFT VER-
SUS HOST DISEASE
Paningbatan, L.; Neumann, J. University of Texas M.D. Anderson
Cancer Center, Houston, Texas
Graft versus host disease (GVHD) of the GI tract requires a
broad management approach. Exploring the complexity and
development of a plan to treat GVHD is central to providing pro-
fessional nursing care. While control of GVHD is important,
recent research has demonstrated the beneﬁt of the graft control-
ling the disease (graft vs. disease effect) therefore measures to stop
the process needs to be undertaken judiciously.
The medical management of GVHD includes drugs for preven-
tion such as cyclosporine, tacrolimus, and mini-dose methrothrex-
ate. First line treatment at our institution is high dose steroids
with 2nd line antithymocyte globulin, mycophenolate, as well as
daclizumab, inﬂiximab, and ABX-CB-9906 on research protocols.
GI biopsies are obtained, and treatment is started even before ﬁnal
pathology results are reported. The patient’s clinical manifesta-
tions of fever, nausea, abdominal cramps, and diarrhea need to be
controlled. Supportive care measures for patients with GI GVHD
include infection prophylaxis, loperamide and/or octreotide, tinc-
ture of opium, analgesics, and keratinizing growth factor. Intra-
venous nutrition usually needs to be started when absorption of
nutrients is impaired across the denuded gut in the most severe
stages of GVHD.
Nursing management focuses on the assessment, collaboration
and communication with the medical team concerning assessment
data, drug therapy administration, patient education, symptom
relief and skin care. Meticulous peri-anal care is essential to pre-
vent skin excoriation, breakdown, and discomfort, as well as a
potential source of infection and sepsis. Nystatin/desitin/xylocaine
(NDX) cream is commonly used for its anesthetic and antifungal
effect along with sitz baths.
The appropriateness and timing of certain clinical interventions
for the control of GVHD is complex. We have established a
“Standard of Care” and an algorithm for the treatment of acute
GI GVHD which are helpful tools in the clinical decision making
process. We are piloting a speciﬁc pathway with the GI depart-
ment to expedite the process of scheduling a GI biopsy. These
tools will be presented with emphasis on the nursing care.
APN/CRA COMMUNICATION STRATEGY FOR A BMT PROGRAM 
Rolland, M.; Armstrong, C.; Yuille, K.
The Hospital for Sick Children (HSC) is a 374 bed pediatric
tertiary care center located in Toronto. A 17 bed Blood and Mar-
row Transplant (BMT) unit handles 70 - 80 autologous and alle-
geneic BMTs per year. HSC is the BMT center for Ontario and
the Maritimes; therefore approximately 45% of patients are
referred from outside institutions. The Clinical Research Associ-
ate (CRA) and two Advanced Practice Nurses (APNs) work closely
together throughout the pre/post BMT period to facilitate patient
process. Patient approval for BMT can happen in one of two ways.
A weekly “fast-track” approach deﬁned as BMT is standard indi-
cation or the patient is participating in a clinical trial with BMT
included in the protocol. A monthly, multidisciplinary BMT
Board meeting discusses cases that may have an increased risk of
morbidity and mortality. All patients “fast-tracked” approved
appear on a master list at this meeting. The CRA enters the
patient demographic information into an administrative database
that generates a list for the weekly scheduling meetings where
dates are assigned. This enables the team to prioritize and antici-
pate resource utilization. There is frequent communication
between meetings with APNs and the CRA as many unanticipated
events occur. A new master list is generated each week for the
scheduling meeting. The CRA attends weekly rounds, collecting
information for reporting to the International Bone Marrow
Transplant Registry. The CRA also functions as the Clinical Tri-
als Coordinator for other BMT related studies thus not duplicat-
ing effort for data collection. Once discharged, daily communica-
tion between the CRA and the APNs provides information on
status changes which is helpful in maintaining an up to date data-
base and accurate reporting of statistics. Our team becomes more
efﬁcient as our program grows and matures. The excellent ﬂow of
communication between the CRA and APNs helps facilitate the
planning stages during the pre BMT period and data accuracy in
the post BMT period. The combination of clinical and research
expertise is a way we strive to provided the best service for our
patients and families.
THE USE OF A MULTIDISCIPLINARY PATIENT CARE CONFERENCE TO
FACILITATE DISCHARGE PLANNING
Smith, V.R. University of Texas MD Anderson Cancer Center, Hous-
ton, Texas
The decision to undergo a bone marrow transplant has an enor-
mous effect on the life of the patient and family members. Fami-
lies approach the transplant with their energies focused on hope
and cure, and often ﬁnd it difﬁcult to make the transition to out-
patient care. In an effort to coordinate care and to help patients
and their families enter into the transition process successfully, we
had to identify and address their concerns and fears regarding dis-
charge. Some of the issues identiﬁed were nutrition, physical and
occupational therapy, insurance coverage issues (i.e., local hous-
ing, home infusion coverage, medication coverage), emotional
and spiritual support. The BMT Clinical Coordinator initiated a
multidisciplinary patient care conference for discharge planning.
The care conference is held weekly to address the progress of the
patient, as well as any complications identiﬁed which may impact
the patient’s discharge plans. This method was successfully imple-
mented in the Bone Marrow Transplant Unit two years ago.
Interventions by the multidisciplinary staff include offering emo-
tional support, providing information and guidance. Members of
the team present at each care conference include: Dietician, Phys-
ical/Occupational Therapist, Chaplain, Social Worker, Case
Manager, Advanced Practice Nurse (representative of the medical
team), Primary Care RN, Clinical Nurse Specialist, Charge
Nurse or Assistant Nurse Manager. The approval for identiﬁed
outpatient services is identiﬁed and initiated at this time. Refer-
rals for outpatient physical/occupational therapy are filled out
during the meeting if a need is established. To meet Joint Com-
mission requirements a Multidisciplinary Patient Care Confer-
ence Record was developed to document the psychosocial issues,
as well as care delivery and plan of care. This record is signed by
all members of the team who are present at the care conference
and placed in the chart, in the progress note section to be viewed
by all caregivers. Adequate support from the multidisciplinary
team during this difﬁcult time can foster emotional support and
alleviate some of the fears about the discharge process for the
patient and their families.
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